No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Starpharma Withdraws Application of SPL7013 Nasal Spray for Market Approval in Australia
2 ASX Healthcare Shares Outperforming Peers on Positive Company News
Starpharma Holdings Ltd: Annual Report to shareholders
Starpharma's DEP Irinotecan Shows Promising Efficacy in Phase 2 Advanced Cancer Trials
We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth
Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16%